Allory Y - Search Results

1

Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival.

Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Boormans JL, Eckstein M, Mertens LS, Boevé ER, Neuzillet Y, Burger M, Pouessel D, Trombetta C, Wullich B, van der Kwast TH, Hartmann A, Allory Y, Lotan Y, Shariat SF, Zuiverloon TCM, Mir MC, van Rhijn BWG. Claps F, et al. Among authors: allory y. World J Urol. 2021 Dec;39(12):4363-4371. doi: 10.1007/s00345-021-03776-5. Epub 2021 Jul 1. World J Urol. 2021. PMID: 34196758 Free article.

2

The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.

Guevara A, Salomon L, Allory Y, Ploussard G, de la Taille A, Paul A, Yiou R, Hoznek A, Dahan M, Abbou CC, Vordos D. Guevara A, et al. Among authors: allory y. J Urol. 2010 Jun;183(6):2161-4. doi: 10.1016/j.juro.2010.02.026. J Urol. 2010. PMID: 20399454

3

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L. Ploussard G, et al. Among authors: allory y. BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30. BJU Int. 2011. PMID: 20883488

4

Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors.

Alenda O, Ploussard G, Mouracade P, Xylinas E, de la Taille A, Allory Y, Vordos D, Hoznek A, Abbou CC, Salomon L. Alenda O, et al. Among authors: allory y. World J Urol. 2011 Oct;29(5):671-6. doi: 10.1007/s00345-010-0620-9. Epub 2010 Nov 24. World J Urol. 2011. PMID: 21107843

5

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.

Rebouissou S, Hérault A, Letouzé E, Neuzillet Y, Laplanche A, Ofualuka K, Maillé P, Leroy K, Riou A, Lepage ML, Vordos D, de la Taille A, Denoux Y, Sibony M, Guyon F, Lebret T, Benhamou S, Allory Y, Radvanyi F. Rebouissou S, et al. Among authors: allory y. J Pathol. 2012 Jul;227(3):315-24. doi: 10.1002/path.4017. Epub 2012 May 8. J Pathol. 2012. PMID: 22422578

6

External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.

Masson-Lecomte A, Vordos D, Hoznek A, Yiou R, Allory Y, Abbou CC, de la Taille A, Salomon L. Masson-Lecomte A, et al. Among authors: allory y. Ann Surg Oncol. 2013 Apr;20(4):1389-94. doi: 10.1245/s10434-012-2753-0. Epub 2012 Dec 4. Ann Surg Oncol. 2013. PMID: 23208127

7

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.

Allory Y, Beukers W, Sagrera A, Flández M, Marqués M, Márquez M, van der Keur KA, Dyrskjot L, Lurkin I, Vermeij M, Carrato A, Lloreta J, Lorente JA, Carrillo-de Santa Pau E, Masius RG, Kogevinas M, Steyerberg EW, van Tilborg AA, Abas C, Orntoft TF, Zuiverloon TC, Malats N, Zwarthoff EC, Real FX. Allory Y, et al. Eur Urol. 2014 Feb;65(2):360-6. doi: 10.1016/j.eururo.2013.08.052. Epub 2013 Sep 7. Eur Urol. 2014. PMID: 24018021 Free article.

8

Location, extent, and multifocality of positive surgical margins for biochemical recurrence prediction after radical prostatectomy.

Ploussard G, Drouin SJ, Rode J, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L. Ploussard G, et al. Among authors: allory y. World J Urol. 2014 Dec;32(6):1393-400. doi: 10.1007/s00345-014-1243-3. Epub 2014 Jan 21. World J Urol. 2014. PMID: 24445447

9

Inflammatory biomarkers and bladder cancer prognosis: a systematic review.

Masson-Lecomte A, Rava M, Real FX, Hartmann A, Allory Y, Malats N. Masson-Lecomte A, et al. Among authors: allory y. Eur Urol. 2014 Dec;66(6):1078-91. doi: 10.1016/j.eururo.2014.07.033. Epub 2014 Aug 20. Eur Urol. 2014. PMID: 25151017 Review.

10

Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.

Masson-Lecomte A, Xylinas E, Bouquot M, Sibony M, Allory Y, Comperat E, Zerbib M, de la Taille A, Rouprêt M. Masson-Lecomte A, et al. Among authors: allory y. World J Urol. 2015 Aug;33(8):1087-93. doi: 10.1007/s00345-014-1387-1. Epub 2014 Sep 2. World J Urol. 2015. PMID: 25179011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters